HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Earnings    EPS Surprises    Mutual Funds    Options    My Account    Help    

Zacks #1 Rank
See how a purely mathematical analysis of earnings estimate revisions returns over 27% per year on average. Click Here to Learn More.
Quote:
Login Free Membership
Search:

Top Zacks Features
Free Membership
Premium Home
Zacks Rank
Equity Research
My Portfolio
Stock Screener
Profit Tracks
Mutual Funds
Options
Zacks Video
RSS Feed
Profit from the Pros

Subscription Services
Product Guide
Zacks Premium
Zacks Elite
Method for Trading
Chart Patterns Trader
Double Your Money
ETF Trader
Growth Trader
Options Trader
Small Cap Trader
Strategic Investor
Surprise Trader
Top 10 Stocks
Value Trader
Special Reports
Research Wizard

Zacks Premium
Get profitable stock
picks and timely
market advice in
Zacks.com`s Free
Daily Newsletter!

Free Registration

View the Archive

NURO: Neurometrix Inc - Stock News Enter Ticker:
 

QuoteEstimatesCharts Company ReportsNewsFinancials
  Company News |  Zacks Commentary
NEUROMETRIX INC (NASD)
NURO 2.45 -0.06 (-2.39%) Vol.  32,873 11.00 CST

Nov 05, 2009 NeuroMetrix Reports Third Quarter 2009 Financial Results
Oct 23, 2009 BiomedReports: News and FDA Updates for Fero (OTC:FROI), NeuroMetrix (Nasdaq:NURO)
Oct 22, 2009 NeuroMetrix, Inc. Announces Date for 2009 Third Quarter Financial Results Conference Call
Sep 23, 2009 Neurometrix Up 109.4% Since SmarTrend's Buy Recommendation
Sep 11, 2009 NeuroMetrix appoints Thomas T Higgins as CFO
Sep 11, 2009 NeuroMetrix raises USD18.7m through private placement
Sep 11, 2009 Higgins Named CFO Of NeuroMetrix
Sep 10, 2009 NeuroMetrix Completes Private Placement Raising $18.7 Million
Sep 10, 2009 NURO: Appointment of Thomas T. Higgins as CFO
Sep 10, 2009 NeuroMetrix Names Thomas T. Higgins Chief Financial Officer
Sep 09, 2009 BiomedReports: News and FDA Updates for NeuroMetrix (NASDAQ:NURO), Martek Biosciences (Nasdaq:MATK)
Sep 08, 2009 NeuroMetrix to Raise $18.68 Million
Aug 07, 2009 BiomedReports: News and FDA Updates for Vertex (Nasdaq:VRTX), Genzyme (Nasdaq:GENZ), NeuroMetrix (Nasdaq:NURO), ARYx (NASDAQ:ARYX)
Aug 06, 2009 BiomedReports: News and FDA Updates for Vertex (Nasdaq:VRTX), Genzyme (Nasdaq:GENZ), NeuroMetrix (Nasdaq:NURO), ARYx (NASDAQ:ARYX)
Aug 05, 2009 NeuroMetrix, Inc. Announces Second Quarter 2009 Financial Results
 
ZACKS COMMENTARY FOR NURO

 
About Zacks | Advertise | Media | Careers | Contact Us | Help
Disclaimer | Privacy Policy | Sitemap
NYSE and AMEX data is at least 20 minutes delayed.  NASDAQ data is at least 15 minutes delayed.
Copyright 2009 Zacks Investment Research